Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Life Sciences, NTT Software, Qiagen, Epoch Bioscience


PerkinElmer Life Sciences of Boston last week announced the full commercial debut of its Protein Array Workstation, an automated slide-based protein microarray processor. The system was developed in collaboration with NexGen Sciences of the UK, and beta- models were unveiled last spring. The ProteinArray Workstation employs a microfluidics system, full software control interface and bar code tracking capability for future integration into PerkinElmer's other protein microarray technologies, the company said. The system can expand to process up to 48 protein microarrays and can use very low sample volumes. The workstation allows automated sample introduction for unattended operation, and can inject up to two separate samples per protein microarray. The system has been developed with an on-line reagent blending facility, the company said.

NTT Software of Boston announced last week the launch of its VisualBio bioinformatics product. The product, which helps researchers visualize gene sequence information, was developed in a partnership with NTT and Riken Genomic Sciences Center in Japan. The products are priced from $16,129.

Qiagen rolled out array-ready oligonucleotide sets for Arabidopsis, Candida albicans, Caenorhabditis elegans, and Drosophila melanogaster genomes. The sets contain 70-mer probes and 26,090, 6266, 7125, and 14,593 characterized genes and/or open reading frames (ORFs), respectively, the company said.

Separately, Qiagen has entered into a non-exclusive licensing agreement to sell Epoch Bioscience's MGB Eclipse Probe gene expression chemistry, the companies said. Epoch will supply components exclusively to Qiagen, which will begin selling custom and standard probe systems in early 2003.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.